Monica Dinulescu Selected Research

Immunotherapy

1/2022	The Association Between Antibiotic Use and Outcome Among Metastatic Melanoma Patients Receiving Immunotherapy.
1/2020	Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica Dinulescu Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 01/2017
5	Melanoma (Melanoma, Malignant) 01/2023 - 01/2020
2	Merkel Cell Carcinoma 10/2023 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2021 - 10/2020
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 09/2023
1	Dysbiosis 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2020
1	Skin Diseases (Skin Disease) 02/2017
1	Drug Hypersensitivity Syndrome 09/2012

Drug/Important Bio-Agent (IBA)

2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2021
2	N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA 01/2021 - 01/2021
2	pembrolizumabIBA 10/2020 - 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 09/2023
1	Proton Pump InhibitorsIBA 01/2023
1	dabrafenibIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	cemiplimabIBA 07/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	AntibodiesIBA 01/2021
1	LigandsIBA 10/2020
1	IpilimumabIBA 01/2020
1	NivolumabIBA 01/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 09/2012

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2017
2	Immunotherapy 01/2022 - 01/2020
1	Radiotherapy 10/2023
1	Drug Therapy (Chemotherapy) 10/2020
1	Lasers (Laser) 02/2017